UROLOGY MAIN SITE GEN. ADULT UROLOGY UROLOGIC ONCOLOGY MALE UROLOGY TRANSPLANT PROGRAM
PELVIC MEDICINE, INCONTINENCE & RECONST. SURGERY PEDIATRIC UROLOGY MIN. INVASIVE SURGERY
About Us
Our History
Faculty Information
Conditions
Innovations & Technology
Research & Clinical
Trials
For Patients
Academic Information
News & Events
Useful Links
Department Directory
Facilities & Directions
How You Can Help
Contact Us
Department of
Urology Intranet

Clinical Trial Details

Trial Information
 
Trial:  Kidney Transplantation - Reducing the Rate of Heart and Blood Vessel Disease in Stable Kidney Transplant Subjects
   
 
Co-Investigator(s):  H. Albin Gritsch, MD;
   
This trial is currently accepting new patient applications.  (Apply)


Objective
  This study will compare the effects of two separate vitamin regimens on the cardiovascular health of kidney transplant recipients over a period of 5 years. 


Trial Design
  This is an “open label” study.  Subjects will have a 50/50 chance of receiving vitamins with high dose combinations of folic acid, B6, and B12, or multivitamins with no folic acid and standard amounts of vitamin B6 and B12.


Patient Eligibility
 
  • 35 to 75 years of age
  • Patients with cancer, end-stage congestive heart failure, liver, or pulmonary disease, progressive HIV or other chronic wasting illness are excluded.

 

* Other inclusion/exclusion criteria apply


For More Information
  A Study to Compare the Use of Multivitamins Containing Folic Acid, Vitamin B6 and B12, versus Multivitamins Containing Vitamin B6 and B12 with No Folic Acid in Reducing the Rate of Heart and Blood Vessel Disease in Stable Kidney Transplant Subjects (Favorit).

Principal Investigator: Gabriel M. Danovitch, M.D., Nephrologist

For more info: Becky Salas, Coordinator. Phone (310) 794-8522